Patents by Inventor Fabrice Marger

Fabrice Marger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of novel antagonist toxins of T-type calcium channel for analgesic purposes
    Patent number: 8664179
    Abstract: A peptide with the following sequence YCQKFLWTCDSERPCCEGLVCRLWCKIN (SEQ ID NO 1) or a derivative thereof, and nucleic acids coding for the peptide having the sequence (SEQ ID NO 1). Also the use of this peptide as an antagonist and/or reverse agonist of T-type calcium channels. A use of the peptide for preparing a drug, in particular an analgesic one.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: March 4, 2014
    Assignees: Centre National de la Recherche Scientifique (CNRS), Universite de Nice Sophia Antipolis
    Inventors: Emmanuel Bourinet, Pierre Escoubas, Fabrice Marger, Joel Nargeot, Michel Lazdunski
  • IDENTIFICATION OF NOVEL ANTAGONIST TOXINS OF T-TYPE CALCIUM CHANNEL FOR ANALGESIC PURPOSES
    Publication number: 20120040909
    Abstract: A peptide with the following sequence YCQKFLWTCDSERPCCEGLVCRLWCKIN (SEQ ID NO 1) or a derivative thereof, and nucleic acids coding for the peptide having the sequence (SEQ ID NO 1). Also the use of this peptide as an antagonist and/or reverse agonist of T-type calcium channels. A use of the peptide for preparing a drug, in particular an analgesic one.
    Type: Application
    Filed: January 15, 2010
    Publication date: February 16, 2012
    Applicants: UNIVERSITE DE NICE SOPHIA ANTIPOLIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
    Inventors: Emmanuel Bourinet, Pierre Escoubas, Fabrice Marger, Joel Nargeot, Michel Lazdunski